Literature DB >> 15491505

The involvement of endothelial progenitor cells in tumor angiogenesis.

Domenico Ribatti1.   

Abstract

Endothelial progenitor cells (EPCs) have been isolated from peripheral blood CD34, VEGFR-2, or AC 133 (CD133) antigen-positive cells, which may home to site of neovascularization and differentiate into endothelial cells in situ. Endothelial cells contribute to tumor angiogenesis, and can originate from sprouting or co-option of neighbouring pre-existing vessels. Emerging evidence indicate that bone marrow-derived circulating EPCs can contribute to tumor angiogenesis and growth of certain tumors. This review article will summarize the literature data concerning this new role played by EPCs in tumor angiogenesis.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15491505      PMCID： PMC6740146          DOI： 10.1111/j.1582-4934.2004.tb00319.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN： 1582-1838            Impact factor:   5.310


  36 in total

Review 1.  Endothelial progenitor cells: current issues on characterization and challenging clinical applications.

Authors:  Thomas Resch; Andreas Pircher; Christian M Kähler; Johann Pratschke; Wolfgang Hilbe
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Neuregulin-1β regulation of embryonic endothelial progenitor cell survival.

Authors:  Radwan N Safa; Xu-Yang Peng; Laura Pentassuglia; Chee Chew Lim; Mathias Lamparter; Cheri Silverstein; Jeremy Walker; Billy Chen; Carrie Geisberg; Antonis K Hatzopoulos; Douglas B Sawyer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-14       Impact factor: 4.733

3.  Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization.

Authors:  Caroline Aspord; Laetitia Tramcourt; Claire Leloup; Jean-Paul Molens; Marie-Therese Leccia; Julie Charles; Joel Plumas
Journal:  J Invest Dermatol       Date:  2014-04-21       Impact factor: 8.551

4.  Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarks.

Authors:  Robert Loewe; Darryl A Oble; Teresa Valero; Lawrence Zukerberg; Martin C Mihm; J Stuart Nelson
Journal:  J Cutan Pathol       Date:  2010-04       Impact factor: 1.587

5.  Angiotensin II-derived reactive oxygen species promote angiogenesis in human late endothelial progenitor cells through heme oxygenase-1 via ERK1/2 and AKT/PI3K pathways.

Authors:  Jingting Mai; Qiong Qiu; Yong Qing Lin; Nian Sang Luo; Hai Feng Zhang; Zhu Zhi Wen; Jing Feng Wang; Chen YangXin
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

6.  Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models.

Authors:  Yingjen Jeffrey Wu; Leslie L Muldoon; Dana Thomas Dickey; Seth J Lewin; Csanad G Varallyay; Edward A Neuwelt
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

7.  Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization.

Authors:  Daniel J Nolan; Alessia Ciarrocchi; Albert S Mellick; Jaspreet S Jaggi; Kathryn Bambino; Sunita Gupta; Emily Heikamp; Michael R McDevitt; David A Scheinberg; Robert Benezra; Vivek Mittal
Journal:  Genes Dev       Date:  2007-06-15       Impact factor: 11.361

Review 8.  Targeting cancer stem cells to modulate alternative vascularization mechanisms.

Authors:  Elena Monzani; Caterina Am La Porta
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

9.  Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization.

Authors:  Debanjan Chakroborty; Uttio Roy Chowdhury; Chandrani Sarkar; Rathindranath Baral; Partha Sarathi Dasgupta; Sujit Basu
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

10.  Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.

Authors:  Colm Morrissey; Lawrence D True; Martine P Roudier; Ilsa M Coleman; Sarah Hawley; Peter S Nelson; Roger Coleman; Ya-Chun Wang; Eva Corey; Paul H Lange; Celestia S Higano; Robert L Vessella
Journal:  Clin Exp Metastasis       Date:  2007-10-31       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.